Ayrshire Capital Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.7M | Buy |
8,592
+765
| +10% | +$596K | 3.22% | 16 |
|
|
2025
Q1 | $6.46M | Buy |
7,827
+145
| +2% | +$120K | 3.13% | 16 |
|
|
2024
Q4 | $5.93M | Buy |
7,682
+256
| +3% | +$198K | 2.89% | 17 |
|
|
2024
Q3 | $6.58M | Buy |
7,426
+732
| +11% | +$649K | 3.13% | 14 |
|
|
2024
Q2 | $6.06M | Buy |
6,694
+69
| +1% | +$62.5K | 3.09% | 13 |
|
|
2024
Q1 | $5.15M | Buy |
6,625
+420
| +7% | +$327K | 2.79% | 21 |
|
|
2023
Q4 | $3.62M | Buy |
6,205
+269
| +5% | +$157K | 2.09% | 27 |
|
|
2023
Q3 | $3.19M | Buy |
+5,936
| New | +$3.19M | 2.06% | 26 |
|